Despite the exceptional year, Orion was able to improve the availability of its medicines. Other key achievements included the establishing of the code of conduct throughout the supply chain and the strengthening of the sustainability awareness of every staff member.
Orion’s systematic work to reduce its carbon footprint has proven effective. The company is therefore making a commitment to an even stricter goal: achieving carbon neutrality in its own operations by 2030.
What kind of journey does a medicine travel from the raw material to the consumer? Click to learn more about the journey of a medicine from product development to consumer use.
Drug residues that end up in water systems can damage the delicate ecosystem of seas and lakes. We can all help to improve the state of the Baltic Sea by taking old and unused medicines to the medicine collection points at pharmacies.
Orion implements responsible medication and states in its value proposition that it wants to be a medicine cabinet for Finns. Based on this, Orion is the sole manufacturer or distributor of many pharmaceuticals in Finland.
Medicines are an important part of our lives and wellbeing, and we struggle to imagine a world without them. Unfortunately, however, human activities tend to leave imprints in the natural environment, and medicines are no exception: they leave residues. A major portion of the residues ends up in the natural environment through waterways.
This is Orion’s third year as a main sponsor of the John Nurminen Foundation. The Foundation’s new Baltic Sea campaigns will help minimise fertiliser emissions at ports and collect our fondest memories of the Baltic Sea.
The numerous suppliers of goods and services, and subcontractors from whom we procure products and services are elementary contributors to our operations and performance, affecting our overall quality. Read here how we ensure that our sources of supply fulfill our requirements.